In Anti-Gene-Patenting Case, Myriad Files for Summary Judgment; USPTO Requests Court to Dismiss Charges
January 20, 2010
In Anti-Gene-Patenting Case, Myriad Files for Summary Judgment; USPTO Requests Court to Dismiss Charges
Myriad would like the court to decide the ACLU's anti-gene-patenting suit ahead of the case going to trial, while the USPTO would like to the court to dismiss the claims against it.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- 'Isolated DNA' Definition May Be Biggest Barrier to Summary Judgment at Anti-Gene Patenting Hearing
February 3, 2010 / Pharmacogenomics Reporter - ACLU, PUBPAT Seek to Challenge Patentability of Isolated Genes Before Supreme Court
October 12, 2011 / Pharmacogenomics Reporter - Appeals Court Says Prometheus Meets Machine/Transformation Test; Impact on Gene Patents Uncertain
December 22, 2010 / Pharmacogenomics Reporter - Myriad Prepared to Make Small IP Sacrifice to Aussies in Light of Landmark US Patent Case
October 6, 2010 / Pharmacogenomics Reporter - Game On: Court Ruling on Myriad Patents to Kick off Protracted Legal Battle Over DNA Patentability
March 31, 2010 / Pharmacogenomics Reporter